New data for KSI-101 from the APEX study reinforce its clinically meaningful vision gains and rapid retinal drying in macular edema secondary to inflammation (MESI)
Addressing Optic Neuropathy Through Neuroinflammation Modulation and IOP Lowering with the ABCD Platform: A Polymedicine Approach to Glaucoma
